<https://rdf.molmedb.upol.cz/reference/ref3265> <http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane46>;
	<http://purl.org/ontology/bibo/pmid> "33529029"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method71>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.0c02112"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490110>;
	<http://purl.org/dc/terms/bibliographicCitation> "Kung PP, Fan C, Gukasyan HJ, Huang B, Kephart S, Kraus M, Lee JH, Sutton SC, Yamazaki S, Zehnder L.: Design and Characterization of a Pyridone-Containing EZH2 Inhibitor Phosphate Prodrug. J Med Chem, Volume 64 (3), 2021"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490111> .
<https://rdf.molmedb.upol.cz/interaction/int1009619> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3265> .
<https://rdf.molmedb.upol.cz/interaction/int1009621> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3265> .